| Hans-Günter Meyer-Thompson | international
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment.
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment.
Fenton, F., Stokes, S. & Eagleton, M.
Ir J Med Sci (2021). doi.org/10.1007/s11845-021-02660-w
https://link.springer.com/article/10.1007/s11845-021-02660-w